Pipeline Programs↗
Active Trials↗
Companies Involved↗
Low back pain is a moderately active landscape with 31 programs across 56 companies. The most active players are Centrexion Therapeutics. 3 programs are in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Bubble size = clinical trials
Key Players
Pipeline
Analysis
96%
Small molecule
26 of 27 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 27 classified programs, each share of the total. Modality classified for 97% of 31 pipeline programs.
Analysis
388
clinical trials
Clinical Trials
388 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)